ETA-DOC-0004·Compound index·Rev 1·Methodology v0.1Provisional — reviewer not yet appointed
compound index · F, page 2 of 3 · methodology v0.1 · reviewer not yet appointed
Compound index · F ETA-DOC-0004

Compound index — F

476 substances begin with F. 1 of them carry an Etalyn grade; the remainder are marked not yet graded, which is a statement about Etalyn’s coverage and not about the substance. This page shows 200 of them, Fish Oil – Fritillaria cirrhosa.

US-DRUGListed as a marketed drug substance in the United StatesEU-MEDActive substance in a centrally authorised EU medicineEU-HERBSubject of an EU herbal monographUS-CSAScheduled under the US Controlled Substances ActCA-NHPLicensed supplement ingredient in CanadaEU-CLAIMAppears in the EU nutrition and health claims registerEU-NOVELAppears in the EU novel food catalogueETALYNEtalyn has graded a claim about this substance
Fish Oil CA-NHPEU-CLAIMEU-NOVELUS-DRUG Not yet graded
Not novel in foodEU claims 0 authorised / 1 refusedCA licensed ingredientUS: drug for further processing
Class as recordedLipid Emulsion [EPC]; Lipids [CS]
Earliest US approval2016
Market presence3 US product listings · 1 FDA applications · 20,886 Canadian licensed products
Parts in scopeConcentrated fish oil high in long chain monounsaturated fatty acids extracted from mackerel and/or herring
Claims examined by the EU — wording reproduced, not Etalyn’s.
Claim as submittedRulingBasisOpinion
“Contributes to thin the blood”Non-authorisedArt.13(1)EFSA opinion
Recorded fromCA-NHP, EU-CLAIM, EU-NOVEL, US-DRUG — 4 of 7 registers
Etalyn identifierETA-C-006300
Fish oil 2 N-3 (EPA, DHA) EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
Claim as submittedRulingBasisOpinion
“Natural stable omega-3 fatty acids help to maintain supple joints. Natural stable omega-3 fatty acids help manage anti-inflammatory responses.”Non-authorisedArt.13(1)EFSA opinion
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-006301
Fish Oil Triglycerides US-DRUG Not yet graded
Earliest US approval2018
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-006303
fish oil VLCPUFA 5 EU-NOVEL Not yet graded
Not novel in food
Parts in scopewhole
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-006304
Fish oil, omega 3 fatty acids EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
Claim as submittedRulingBasisOpinion
“Helps maintain joint mobility and flexibility. Helps diminish morning stiffness in joints.”Non-authorisedArt.13(1)EFSA opinion
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-006302
Fish oils / Omega 3 fatty acids EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
Claim as submittedRulingBasisOpinion
“Fish oils / Omega-3 oils from fish / EPA and DHA may help to control / regulate blood lipids / lipid profile Fish oils / Omega-3 oils from fish / EPA and DHA help support a healthy heart”Non-authorisedArt.13(1)EFSA opinion
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-006305
Fish peptide extract CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-006306
Fish protein EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
Claim as submittedRulingBasisOpinion
“Fish protein is combination of substances for a beautiful skin”Non-authorisedArt.13(1)EFSA opinion
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-006307
Fish protein hydrolysate CA-NHP Not yet graded
CA licensed ingredient
Market presence19 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-006308
Fish proteins and polysaccharides CA-NHP Not yet graded
CA licensed ingredient
Market presence5 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-006309
Fitusiran US-DRUG Not yet graded
US: bulk ingredient
Class as recordedAntithrombin-directed RNA Interaction [EPC]; Decreased RNA Integrity [PE]; Increased RNA Degradation [PE]; RNA
Earliest US approval2025
Market presence4 US product listings · 1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-006310
Flammulina velutipes CA-NHP Not yet graded
CA licensed ingredient
Market presence20 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-006311
Flavin Adenine Dinucleotide US-DRUG Not yet graded
US: unapproved drug other
Class as recordedAcidifying Activity [MoA]; Anti-coagulant [EPC]; Ascorbic Acid [CS]; Calcium Chelating Activity [MoA]
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-006312
Flavonoids from green tea, apple and onion EU-CLAIM Not yet graded
EU claims 0 authorised / 2 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
Claim as submittedRulingBasisOpinion
“Exceptionally strong organic antioxidant.”Non-authorisedArt.13(1)EFSA opinion
“Flavonoids, especially catechins from green tea, reduce the absorption of carbohydrates by 25%. Carbohydrates account for 49% of total energy. Thus the weight slimming effect is a total of 12%. Reduces visceral fat”Non-authorisedArt.13(1)EFSA opinion
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-006313
Flavonoids in cranberry juice EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
Claim as submittedRulingBasisOpinion
“Flavonoids are natural, health-promoting antioxidants.”Non-authorisedArt.13(1)EFSA opinion
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-006314
Flavoxate Hydrochloride US-DRUG Not yet graded
US: anda
Class as recordedCholinergic Muscarinic Antagonist [EPC]; Cholinergic Muscarinic Antagonists [MoA]
Earliest US approval1970
Market presence5 US product listings · 4 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-006315
Flax (Linum usitatissimum) EU-CLAIM Not yet graded
EU claims 0 authorised / 2 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
Claim as submittedRulingBasisOpinion
“Helps to support mood. Contributes to emotionnal well-being. Helps to support relaxation and mental well-being. Contributes to optimal relaxation.”Non-authorisedArt.13(1)EFSA opinion
“Helps to support mood. Contributes to emotionnal well-being. Helps to support relaxation and mental well-being. Contributes to optimal relaxation. Clarification provided Thanks to its high essential fatty acids content, flax enhances mood. Flax increases relaxation.”Non-authorisedArt.13(1)EFSA opinion
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-006316
Flax Seed US-DRUG Not yet graded
US: bla
Class as recordedAdrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]; Allergens [CS]; Bee Venoms [CS]
Market presence23 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-006317
Flaxseed oil CA-NHPEU-CLAIM Not yet graded
EU claims 0 authorised / 1 refusedCA licensed ingredient
Market presence5 Canadian licensed products
Claims examined by the EU — wording reproduced, not Etalyn’s.
Claim as submittedRulingBasisOpinion
“Stabilises moods.”Non-authorisedArt.13(1)EFSA opinion
Recorded fromCA-NHP, EU-CLAIM — 2 of 7 registers
Etalyn identifierETA-C-006318
Flaxseed oil/alpha-linoleic acid EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
Claim as submittedRulingBasisOpinion
“Promotes heart health”Non-authorisedArt.13(1)EFSA opinion
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-006319
Flaxseed Protein CA-NHP Not yet graded
CA licensed ingredient
Market presence38 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-006320
Flecainide Acetate US-DRUG Not yet graded
US: anda
Class as recordedAntiarrhythmic [EPC]
Earliest US approval1985
Market presence68 US product listings · 11 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-006321
Flemingia macrophylla CA-NHP Not yet graded
CA licensed ingredient
Market presence10 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-006322
Flemingia philippinensis CA-NHP Not yet graded
CA licensed ingredient
Market presence37 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-006323
Flemingia prostrata CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-006324
Flibanserin US-DRUG Not yet graded
US: bulk ingredient
Class as recordedP-Glycoprotein Inhibitors [MoA]
Earliest US approval2015
Market presence7 US product listings · 1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-006325
florbetaben (18F) EU-MED Not yet graded
EU medicine: Authorised
Class as recordedV09AX06
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-006326
Florbetaben F-18 US-DRUG Not yet graded
US: nda
Class as recordedPositron Emitting Activity [MoA]; Radioactive Diagnostic Agent [EPC]
Earliest US approval2014
Market presence1 US product listings · 1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-006327
florbetapir (18F) EU-MED Not yet graded
EU medicine: Authorised
Class as recordedV09AX05
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-006328
Florbetapir F-18 US-DRUG Not yet graded
US: nda
Class as recordedPositron Emitting Activity [MoA]; Radioactive Diagnostic Agent [EPC]
Earliest US approval2012
Market presence1 US product listings · 1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-006329
Florfenicol EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bulk ingredient
Market presence3 US product listings · 3 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-006330
Flortaucipir (18F) EU-MED Not yet graded
EU medicine: Authorised
Class as recordedV09AX07
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-006331
Flortaucipir F-18 US-DRUG Not yet graded
US: nda
Earliest US approval2020
Market presence1 US product listings · 1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-006332
Flos chrysanthemi CA-NHP Not yet graded
CA licensed ingredient
Market presence4 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-006333
Flos lonicerae CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-006334
Flotufolastat F-18 US-DRUG Not yet graded
US: nda
Class as recordedPositron Emitting Activity [MoA]; Radioactive Diagnostic Agent [EPC]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-006335
Flotufolastat F-18 Gallium US-DRUG Not yet graded
Earliest US approval2023
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-006336
Flounder, Unspecified US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Dietary [EXT]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-006337
Flour from Buckwheat seedlings with a high spermidine content EU-NOVEL Not yet graded
Novel, not yet authorised
Parts in scopeWhole
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-006338
Floxuridine US-DRUG Not yet graded
US: anda
Class as recordedAntimetabolite [EPC]; Deoxyuridine [CS]
Earliest US approval1970
Market presence4 US product listings · 5 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-006339
Flualprazolam (8-chloro-6-(2-fluorophenyl)-1-methyl-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine) US-CSA Not yet graded
CSA Schedule I
also: Flualprazolam -1-methyl-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine)
Class as recordedDEA: depressant
Recorded fromUS-CSA — 1 of 7 registers
Etalyn identifierETA-C-006340
Flubendazole US-DRUG Not yet graded
US: bulk ingredient
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-006341
Flubromazolam (8-bromo-6-(2-fluorophenyl)-1-methyl-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine) [1,2,4]triazolo[4,3-a][1,4]benzodiazepine US-CSA Not yet graded
CSA Schedule I
also: Flubromazolam -1-methyl-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine) [1,2,4]triazolo[4,3-a][1,4]benzodiazepine
Class as recordedDEA: depressant
DEA other names8-Bromo-6-(2-fluorophenyl)-1-methyl-4H-
Recorded fromUS-CSA — 1 of 7 registers
Etalyn identifierETA-C-006342
fluciclovine (18F) EU-MED Not yet graded
EU medicine: Authorised
Class as recordedV09IX12
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-006343
Fluciclovine F-18 US-DRUG Not yet graded
US: nda
Class as recordedPositron Emitting Activity [MoA]; Radioactive Diagnostic Agent [EPC]
Earliest US approval2016
Market presence1 US product listings · 1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-006344
Fluconazole US-DRUG Not yet graded
US: anda
Class as recordedAzole Antifungal [EPC]; Azoles [CS]; Cytochrome P450 2C19 Inhibitors [MoA]; Cytochrome P450 2C9 Inhibitors [MoA]
Earliest US approval1990
Market presence183 US product listings · 46 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-006345
Flucytosine US-DRUG Not yet graded
US: anda
Class as recordedNucleoside Analog Antifungal [EPC]; Nucleoside Analog [EXT]
Earliest US approval1971
Market presence27 US product listings · 8 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-006346
Fludarabine US-DRUG Not yet graded
US: anda
Class as recordedNucleic Acid Synthesis Inhibitors [MoA]; Nucleoside Metabolic Inhibitor [EPC]
Earliest US approval1991
Market presence9 US product listings · 14 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-006347
Fludeoxyglucose F-18 US-DRUG Not yet graded
US: anda
Class as recordedRadioactive Diagnostic Agent [EPC]; Radiopharmaceutical Activity [MoA]
Earliest US approval1994
Market presence26 US product listings · 44 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-006348
Fludiazepam US-CSA Not yet graded
CSA Schedule IV
Class as recordedDEA: depressant
Recorded fromUS-CSA — 1 of 7 registers
Etalyn identifierETA-C-006349
Fludrocortisone Acetate US-DRUG Not yet graded
US: anda
Earliest US approval1955
Market presence21 US product listings · 8 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-006350
Flueggea virosa CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-006351
Flumazenil US-DRUG Not yet graded
US: anda
Class as recordedBenzodiazepine Antagonist [EPC]
Earliest US approval1991
Market presence25 US product listings · 10 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-006352
Flumethasone US-DRUG Not yet graded
US: bulk ingredient
Market presence3 US product listings · 1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-006353
Flunarizine Hydrochloride US-DRUG Not yet graded
US: bulk ingredient
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-006354
Flunisolide US-DRUG Not yet graded
US: anda
Class as recordedCorticosteroid Hormone Receptor Agonists [MoA]; Corticosteroid [EPC]
Earliest US approval1981
Market presence7 US product listings · 8 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-006355
Flunitazene (N,N-diethyl-2-(2-(4-fluorobenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine) US-CSA Not yet graded
CSA Schedule Inarcotic
also: Flunitazene -5-nitro-1H-benzimidazol-1-yl)ethan-1-amine)
Class as recordedDEA: narcotic / opioid
Recorded fromUS-CSA — 1 of 7 registers
Etalyn identifierETA-C-006356
Flunitrazepam US-CSA Not yet graded
CSA Schedule IV
Class as recordedDEA: depressant
DEA other namesRohypnol; Narcozep; Darkene; Roipnol
Recorded fromUS-CSA — 1 of 7 registers
Etalyn identifierETA-C-006357
Flunixin Meglumine US-DRUG Not yet graded
US: bulk ingredient
Market presence7 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-006358
Fluocinolone Acetonide EU-MEDUS-DRUG Not yet graded
EU medicine: Application withdrawnUS: anda
Class as recordedAminoglycoside Antibacterial [EPC]; Aminoglycosides [CS]; Corticosteroid Hormone Receptor Agonists [MoA]; Corticosteroid [EPC]
Earliest US approval1963
Market presence61 US product listings · 80 FDA applications · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-006359
Fluocinonide US-DRUG Not yet graded
US: anda
Class as recordedCorticosteroid Hormone Receptor Agonists [MoA]; Corticosteroid [EPC]
Earliest US approval1971
Market presence61 US product listings · 47 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-006360
Fluorescein US-DRUG Not yet graded
US: anda
Class as recordedDiagnostic Dye [EPC]; Dyes [MoA]; Local Anesthesia [PE]; Local Anesthetic [EPC]
Earliest US approval1976
Market presence23 US product listings · 8 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-006361
Fluoric acid CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-006363
Fluoricum acidum CA-NHP Not yet graded
CA licensed ingredient
Market presence3 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-006364
Fluoride CA-NHPEU-CLAIM Not yet graded
EU claims 1 authorised / 1 refusedCA licensed ingredient
Market presence50 Canadian licensed products
Claims examined by the EU — wording reproduced, not Etalyn’s.
Claim as submittedRulingBasisOpinion
“Fluoride contributes to the maintenance of tooth mineralisation”AuthorisedArt.13(1)EFSA opinion
“Fluoride supports the mineralisation of bones.”Non-authorisedArt.13(1)EFSA opinion
Recorded fromCA-NHP, EU-CLAIM — 2 of 7 registers
Etalyn identifierETA-C-006365
Fluoride ION CA-NHPUS-DRUG Not yet graded
CA licensed ingredientUS: otc monograph drug
Class as recordedAllergens [CS]; Calcium [CS]; Calcium [EPC]; Cell-mediated Immunity [PE]
Market presence5 US product listings · 2 Canadian licensed products
Recorded fromCA-NHP, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-006366
Fluorine CA-NHPUS-DRUG Not yet graded
CA licensed ingredientUS: unapproved homeopathic
Class as recordedAllergens [CS]; Bee Venoms [CS]; Cell-mediated Immunity [PE]; Copper Absorption Inhibitor [EPC]
Market presence2 US product listings · 5 Canadian licensed products
Recorded fromCA-NHP, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-006367
Fluorite CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-006368
Fluorodopa F-18 US-DRUG Not yet graded
US: nda
Earliest US approval2019
Market presence2 US product listings · 1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-006369
Fluoroestradiol F-18 US-DRUG Not yet graded
US: nda
Class as recordedPositron Emitting Activity [MoA]; Radioactive Diagnostic Agent [EPC]
Earliest US approval2020
Market presence1 US product listings · 1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-006362
Fluorometholone US-DRUG Not yet graded
US: anda
Class as recordedCorticosteroid Hormone Receptor Agonists [MoA]; Corticosteroid [EPC]
Earliest US approval1972
Market presence15 US product listings · 10 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-006370
Fluorouracil US-DRUG Not yet graded
US: anda
Class as recordedNucleic Acid Synthesis Inhibitors [MoA]; Nucleoside Metabolic Inhibitor [EPC]
Earliest US approval1962
Market presence60 US product listings · 52 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-006371
Fluoxetine EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: anda
Class as recordedAtypical Antipsychotic [EPC]; Serotonin Reuptake Inhibitor [EPC]; Serotonin Uptake Inhibitors [MoA]
Earliest US approval1987
Market presence279 US product listings · 80 FDA applications · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-006372
Fluoxymesterone US-CSAUS-DRUG Not yet graded
CSA Schedule IIIUS: bulk ingredient
Class as recordedDEA: anabolic steroid
Earliest US approval1956
Market presence2 US product listings · 8 FDA applications
DEA other namesAnadroid-F; Halotestin; Ora-Testryl
Recorded fromUS-CSA, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-006373
Fluphenazine Decanoate US-DRUG Not yet graded
US: anda
Class as recordedPhenothiazine [EPC]; Phenothiazines [CS]
Earliest US approval1959
Market presence132 US product listings · 53 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-006374
Fluprednisolone US-DRUG Not yet graded
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-006375
Fluralaner EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bulk ingredient
Class as recordedQP53BE02
Market presence5 US product listings · 6 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-006376
Flurandrenolide US-DRUG Not yet graded
US: anda
Class as recordedCorticosteroid Hormone Receptor Agonists [MoA]; Corticosteroid [EPC]
Earliest US approval1963
Market presence8 US product listings · 10 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-006377
Flurazepam US-CSAUS-DRUG Not yet graded
CSA Schedule IVUS: anda
Class as recordedBenzodiazepine [EPC]; Benzodiazepines [CS]; DEA: depressant
Earliest US approval1970
Market presence4 US product listings · 23 FDA applications
DEA other namesDalmane
Recorded fromUS-CSA, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-006378
Flurbiprofen US-DRUG Not yet graded
US: anda
Class as recordedAnti-Inflammatory Agents; Cyclooxygenase Inhibitors [MoA]; Non-Steroidal [CS]; Nonsteroidal Anti-inflammatory Drug [EPC]
Earliest US approval1986
Market presence23 US product listings · 11 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-006379
Flurpiridaz F-18 US-DRUG Not yet graded
US: nda
Class as recordedPositron Emitting Activity [MoA]; Radioactive Diagnostic Agent [EPC]
Earliest US approval2024
Market presence1 US product listings · 1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-006380
Flutamide US-DRUG Not yet graded
US: anda
Class as recordedAndrogen Receptor Antagonists [MoA]; Androgen Receptor Inhibitor [EPC]
Earliest US approval1989
Market presence6 US product listings · 6 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-006381
flutemetamol (18F) EU-MED Not yet graded
EU medicine: Authorised
Class as recordedV09AX04
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-006382
Flutemetamol F-18 US-DRUG Not yet graded
US: nda
Class as recordedRadioactive Diagnostic Agent [EPC]; Radiopharmaceutical Activity [MoA]
Earliest US approval2013
Market presence1 US product listings · 1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-006383
Fluticasone Furoate EU-MEDUS-DRUG Not yet graded
EU medicine: Authorised, LapsedUS: anda
Class as recordedAdrenergic beta2-Agonists [MoA]; Anticholinergic [EPC]; Cholinergic Antagonists [MoA]; Corticosteroid Hormone Receptor Agonists [MoA]
Earliest US approval1990
Market presence274 US product listings · 51 FDA applications · 7 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-006384
Fluticasone Propionate-17.beta.-Carboxylic Acid US-DRUG Not yet graded
US: bulk ingredient for human prescription compounding
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-006385
Fluvastatin Sodium US-DRUG Not yet graded
US: anda
Class as recordedHMG-CoA Reductase Inhibitor [EPC]; Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]
Earliest US approval1993
Market presence21 US product listings · 8 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-006386
Fluvoxamine Maleate US-DRUG Not yet graded
US: anda
Class as recordedSerotonin Reuptake Inhibitor [EPC]; Serotonin Uptake Inhibitors [MoA]
Earliest US approval1994
Market presence52 US product listings · 27 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-006387
Foeniculi amari fructus EU-HERB Not yet graded
Herbal monograph: F: Assessment finalised
also: Bitter Fennel; Bitter Fennel Fruit Oil; Foeniculi amari fructus aetheroleum; Foeniculum vulgare Miller subsp. vulgare var. vulgare
Class as recordedherbal: Cough and cold; herbal: Urinary tract and genital disorders;Cough and cold
Recorded fromEU-HERB — 1 of 7 registers
Etalyn identifierETA-C-006388
Foeniculi dulcis fructus EU-HERB Not yet graded
Herbal monograph: F: Assessment finalised
also: Sweet Fennel; Foeniculum vulgare Miller subsp. vulgare var. dulce (Mill.) Batt. & Trab.
Class as recordedherbal: Urinary tract and genital disorders;Cough and cold
Recorded fromEU-HERB — 1 of 7 registers
Etalyn identifierETA-C-006389
Foeniculum vulgare CA-NHPEU-NOVEL Not yet graded
Not novel in foodCA licensed ingredient
Market presence355 Canadian licensed products
Parts in scopeLeaves (petiole), fruits (schizocarp) and shoots; Aerial parts
Recorded fromCA-NHP, EU-NOVEL — 2 of 7 registers
Etalyn identifierETA-C-006390
Foeniculum Vulgare Fruit US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAdrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Adrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]
Market presence16 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-006391
Foeniculum vulgare ssp vulgare var vulgare CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-006392
Foeniculum vulgare subsp. vulgare var. dulce CA-NHP Not yet graded
CA licensed ingredient
Market presence415 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-006393
Foeniculum vulgare subsp. vulgare var. vulgare CA-NHP Not yet graded
CA licensed ingredient
Market presence119 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-006394
Foeniculum vulgare var. dulce CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-006395
Foeniculum vulgare var. vulgare CA-NHP Not yet graded
CA licensed ingredient
Market presence8 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-006396
Foeniculum Vulgare Var. Vulgare Whole US-DRUG Not yet graded
US: unapproved homeopathic
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-006397
Foie de chimère EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
Claim as submittedRulingBasisOpinion
“Renforce les défenses naturelles Soutient le système de défense”Non-authorisedArt.13(1)EFSA opinion
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-006398
Folate CA-NHPEU-CLAIMUS-DRUG Not yet graded
EU claims 8 authorised / 0 refusedCA licensed ingredientUS: unapproved drug other
Class as recordedVitamin D [CS]; Vitamin D [EPC]
Market presence2 US product listings · 10,704 Canadian licensed products
Claims examined by the EU — wording reproduced, not Etalyn’s.
Claim as submittedRulingBasisOpinion
“Folate contributes to maternal tissue growth during pregnancy”AuthorisedArt.13(1)EFSA opinion
“Folate contributes to normal amino acid synthesis”AuthorisedArt.13(1)EFSA opinion
“Folate contributes to normal blood formation”AuthorisedArt.13(1)EFSA opinion
“Folate contributes to normal homocysteine metabolism”AuthorisedArt.13(1)EFSA opinion
“Folate contributes to normal psychological function”AuthorisedArt.13(1)EFSA opinion
“Folate contributes to the normal function of the immune system”AuthorisedArt.13(1)EFSA opinion
“Folate contributes to the reduction of tiredness and fatigue”AuthorisedArt.13(1)EFSA opinion
“Folate has a role in the process of cell division”AuthorisedArt.13(1)EFSA opinion
Recorded fromCA-NHP, EU-CLAIM, US-DRUG — 3 of 7 registers
Etalyn identifierETA-C-006399
Folic Acid CA-NHPEU-CLAIMEU-MEDUS-DRUG Not yet graded
EU medicine: Application withdrawnEU claims 1 authorised / 5 refusedCA licensed ingredientUS: anda
Class as recordedAcidifying Activity [MoA]; Allergens [CS]; Ammonium Ion Binding Activity [MoA]; Analogs/Derivatives [Chemical/Ingredient]
Earliest US approval1946
Market presence219 US product listings · 57 FDA applications · 1 EU medicines · 35 Canadian licensed products
Claims examined by the EU — wording reproduced, not Etalyn’s.
Claim as submittedRulingBasisOpinion
“B-vitamins and vitamin C are essential for the energy metabolism / the transfomation of food into energy”Non-authorisedArt.13(1)EFSA opinion
“Folic acid protects the eye Folic acid important for the eye”Non-authorisedArt.13(1)EFSA opinion
“Positive affect for protection of the lens”Non-authorisedArt.13(1)EFSA opinion
“Supplemental folic acid intake increases maternal folate status. Low maternal folate status is a risk factor in the development of neural tube defects in the developing foetus.”AuthorisedArt.14(1)(a)EFSA opinion
“Contributes to healthy arteries and vessels; Helps promote heart health.”Non-authorisedArt.13(1)EFSA opinion
“- Helps keep arteries/blood vessels healthy; - Contributes to healthy arteries/ blood vessels; - Supports heart health by contributing to the normal functioning of the arteries/blood vessels; - Helps maintain a normal blood pressure by supporting the elasticity of blood vessels/arteries;”Non-authorisedArt.13(1)EFSA opinion
Recorded fromCA-NHP, EU-CLAIM, EU-MED, US-DRUG — 4 of 7 registers
Etalyn identifierETA-C-006400
Folium sennae CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-006401
Folliculinum CA-NHP Not yet graded
CA licensed ingredient
Market presence24 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-006402
Follistatin-344 ETALYN E/insufficientband 6
Recorded from — 0 of 7 registers
Etalyn identifierETA-C-006403
Follitropin US-DRUG Not yet graded
US: bla
Class as recordedAndrogen Receptor Agonists [MoA]; Androgen [EPC]; Androstanes [CS]; Catecholamine [EPC]
Market presence9 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-006404
follitropin alfa EU-MED Not yet graded
EU medicine: Authorised
Class as recordedG03GA05; G03GA30
Market presence4 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-006405
Follitropin Alfa/beta US-DRUG Not yet graded
Earliest US approval1997
Market presence6 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-006406
follitropin beta EU-MED Not yet graded
EU medicine: Authorised, Withdrawn
Class as recordedG03GA06
Market presence2 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-006407
follitropin delta EU-MED Not yet graded
EU medicine: Authorised
Class as recordedG03GA10
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-006408
Follow-on formulae with a fixed combination of short-chain galacto-oligosaccharides, acidified milk, nucleotides and beta-palmitate EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
Claim as submittedRulingBasisOpinion
“Aids minor intestinal ailments (as colic, constipation, digestive symptoms)”Non-authorisedArt.14(1)(b)EFSA opinion
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-006409
Fomepizole US-DRUG Not yet graded
US: anda
Class as recordedAntidote [EPC]
Earliest US approval1997
Market presence13 US product listings · 6 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-006410
Fomes fomentarius CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-006411
Fomitopsis pinicola CA-NHP Not yet graded
CA licensed ingredient
Market presence4 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-006412
Fomitopsis Pinicola Fruiting Body US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Grain Proteins [EXT]
Market presence4 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-006413
fomivirsen EU-MEDUS-DRUG Not yet graded
EU medicine: Withdrawn
Class as recordedS01AD08
Earliest US approval1998
Market presence1 FDA applications · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-006414
Fondaparinux Sodium EU-MEDUS-DRUG Not yet graded
EU medicine: Authorised, WithdrawnUS: anda
Class as recordedB01AX05; Factor Xa Inhibitor [EPC]; Factor Xa Inhibitors [MoA]
Earliest US approval2001
Market presence33 US product listings · 7 FDA applications · 2 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-006415
Food Category: Fish Food: Cultured Sea bass and Gilthead Sea bream Food Component / Nutrient: EPA & DHA Omega 3 Highly Unsaturated fatty acids EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
Claim as submittedRulingBasisOpinion
“Eating cultured sea bass and gilthead sea bream twice a week, as a rich source of omega-3 highly unsaturated fatty acids and part of a healthy lifestyle, has been shown to help maintain heart health”Non-authorisedArt.13(1)EFSA opinion
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-006416
Food reduced/ low/ free of energy EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
Claim as submittedRulingBasisOpinion
“[x] helps maintain your body weight (as part of a calorie controlled diet).”Non-authorisedArt.13(1)EFSA opinion
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-006417
Food supplement /Food ingredient : Whole cranberry powder from North American Cranberry (Vaccinium macrocarpon) Early Black species. EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
Claim as submittedRulingBasisOpinion
“Helps to maintain the health of the urinary system. Contributes to urinary tract health. Has a beneficial effect on the urinary system. Helps to eliminate pathogenic bacteria from urinary tract.”Non-authorisedArt.13(1)EFSA opinion
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-006418
Food supplement with 5-hydroxytryptophane (5- HTP) EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
Claim as submittedRulingBasisOpinion
“Helps to reduce the caloric intake Assists controlling portions and snacking Promotes the syntheses of serotonin, a known satiety factor”Non-authorisedArt.13(1)EFSA opinion
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-006419
Food with a reduced glycemic response EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
Claim as submittedRulingBasisOpinion
“Due to its (modified) carbohydrate composition, this food has a lower blood glucose and insulin response; This food has a [x%] lower impact on blood sugar levels than comparable foods and thus helps to maintain more steady blood sugar levels graphical presentations of blood glucose response curves]”Non-authorisedArt.13(1)EFSA opinion
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-006420
Foods with a low or reduced content of saturated fatty acids EU-CLAIM Not yet graded
EU claims 1 authorised / 0 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
Claim as submittedRulingBasisOpinion
“Reducing consumption of saturated fat contributes to the maintenance of normal blood cholesterol levels”AuthorisedArt.13(1)EFSA opinion
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-006422
Foods with a low or reduced content of sodium EU-CLAIM Not yet graded
EU claims 1 authorised / 0 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
Claim as submittedRulingBasisOpinion
“Reducing consumption of sodium contributes to the maintenance of normal blood pressure”AuthorisedArt.13(1)EFSA opinion
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-006421
Formaldehyde CA-NHPUS-DRUG Not yet graded
CA licensed ingredientUS: unapproved homeopathic
Class as recordedAcidifying Activity [MoA]; Adrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Allergens [CS]
Market presence18 US product listings · 1 Canadian licensed products
Recorded fromCA-NHP, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-006423
Formaldehyde Solution CA-NHPUS-DRUG Not yet graded
CA licensed ingredientUS: unapproved homeopathic
Class as recordedAcidifying Activity [MoA]; Adrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Adrenocorticotropic Hormone [CS]
Market presence30 US product listings · 1 Canadian licensed products
Recorded fromCA-NHP, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-006424
Formebolone US-CSA Not yet graded
CSA Schedule III
Class as recordedDEA: anabolic steroid
DEA other namesEsiclene; Hubernol
Recorded fromUS-CSA — 1 of 7 registers
Etalyn identifierETA-C-006425
Formic Acid EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: drug for further processing
Class as recordedAcidifying Activity [MoA]; Allergens [CS]; Ammonium Ion Binding Activity [MoA]; Animal Fur [CS]
Market presence32 US product listings · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-006426
Formica Rufa CA-NHPUS-DRUG Not yet graded
CA licensed ingredientUS: unapproved homeopathic
Class as recordedAllergens [CS]; Allogeneic Cultured Cell Scaffold [EPC]; Ammonium Ion Binding Activity [MoA]; Antimalarial [EPC]
Market presence67 US product listings · 20 Canadian licensed products
Recorded fromCA-NHP, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-006427
Formicum acidum CA-NHP Not yet graded
CA licensed ingredient
Market presence15 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-006428
Formoterol EU-MEDUS-DRUG Not yet graded
EU medicine: Authorised, WithdrawnUS: anda
Class as recordedAdrenergic beta2-Agonists [MoA]; Anticholinergic [EPC]; Cholinergic Antagonists [MoA]; Cholinergic Muscarinic Antagonist [EPC]
Earliest US approval2001
Market presence67 US product listings · 23 FDA applications · 13 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-006429
Formulated palm and oat oil emulsion EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
Claim as submittedRulingBasisOpinion
“Helps to eat less. Helps to reduce weight regain after dieting.”Non-authorisedArt.13(1)EFSA opinion
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-006430
Forsythia suspensa CA-NHP Not yet graded
CA licensed ingredient
Market presence637 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-006431
Forsythia Suspensa Fruit US-DRUG Not yet graded
US: unapproved drug other
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Food Additives [CS]
Market presence6 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-006432
Fortunella japonica CA-NHP Not yet graded
CA licensed ingredient
Market presence3 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-006433
Fosamprenavir Calcium EU-MEDUS-DRUG Not yet graded
EU medicine: WithdrawnUS: anda
Class as recordedCytochrome P450 3A4 Inducers [MoA]; Cytochrome P450 3A4 Inhibitors [MoA]; HIV Protease Inhibitors [MoA]; J05AE07
Earliest US approval2003
Market presence4 US product listings · 5 FDA applications · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-006434
fosaprepitant EU-MED Not yet graded
EU medicine: Authorised
Class as recordedA04AD12
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-006435
Fosaprepitant Dimeglumine US-DRUG Not yet graded
US: anda
Class as recordedCytochrome P450 2C9 Inducers [MoA]; Cytochrome P450 3A4 Inducers [MoA]; Cytochrome P450 3A4 Inhibitors [MoA]; Neurokinin 1 Antagonists [MoA]
Earliest US approval2008
Market presence41 US product listings · 23 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-006436
Foscarbidopa US-DRUG Not yet graded
US: bulk ingredient
Earliest US approval2024
Market presence4 US product listings · 1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-006437
Foscarnet Sodium US-DRUG Not yet graded
US: anda
Class as recordedChelating Activity [MoA]; DNA Polymerase Inhibitors [MoA]; Pyrophosphate Analog DNA Polymerase Inhibitor [EPC]; Pyrophosphate Analog [EXT]
Earliest US approval1991
Market presence15 US product listings · 8 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-006438
Fosdenopterin Hydrobromide EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: drug for further processing
Class as recordedA16AX19; Cyclic Pyranopterin Monophosphate [EPC]; Cyclic Pyranopterin Monophosphate [EXT]
Earliest US approval2021
Market presence2 US product listings · 1 FDA applications · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-006439
Fosfomycin Sodium US-DRUG Not yet graded
US: anda
Earliest US approval1996
Market presence21 US product listings · 9 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-006440
Fosinopril Sodium US-DRUG Not yet graded
US: anda
Class as recordedAngiotensin Converting Enzyme Inhibitor [EPC]; Angiotensin-converting Enzyme Inhibitors [MoA]; Increased Diuresis [PE]; Thiazide Diuretic [EPC]
Earliest US approval1991
Market presence33 US product listings · 22 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-006441
Foslevodopa US-DRUG Not yet graded
US: bulk ingredient
Earliest US approval2024
Market presence4 US product listings · 1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-006442
Fosnetupitant US-DRUG Not yet graded
US: bulk ingredient
Class as recordedSerotonin 3 Receptor Antagonists [MoA]; Serotonin-3 Receptor Antagonist [EPC]
Earliest US approval2018
Market presence3 US product listings · 1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-006443
Fosphenytoin Sodium US-DRUG Not yet graded
US: anda
Class as recordedAnti-epileptic Agent [EPC]; Cytochrome P450 1A2 Inducers [MoA]; Cytochrome P450 2B6 Inducers [MoA]; Cytochrome P450 2C19 Inducers [MoA]
Earliest US approval1996
Market presence20 US product listings · 16 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-006444
Fospropofol US-CSAUS-DRUG Not yet graded
CSA Schedule IVUS: bulk ingredient
Class as recordedDEA: depressant
Earliest US approval2008
Market presence1 US product listings · 1 FDA applications
DEA other namesLusedra
Recorded fromUS-CSA, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-006445
Fosravuconazole L-LYSINE Ethanolate US-DRUG Not yet graded
US: bulk ingredient
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-006446
Fostamatinib EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bulk ingredient
Class as recordedB02BX
Earliest US approval2018
Market presence4 US product listings · 2 FDA applications · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-006447
fostemsavir trometamol EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bulk ingredient
Class as recordedJ05AX
Earliest US approval2020
Market presence2 US product listings · 1 FDA applications · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-006448
FR-179642 US-DRUG Not yet graded
US: bulk ingredient
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-006449
Fragaria ananassa CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-006450
Fragaria Ananassa (strawberry) Fruit US-DRUG Not yet graded
US: otc monograph drug
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Fruit Proteins [EXT]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-006451
Fragaria chiloensis CA-NHP Not yet graded
CA licensed ingredient
Market presence15 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-006452
Fragaria spp. CA-NHP Not yet graded
CA licensed ingredient
Market presence5 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-006453
Fragaria vesca CA-NHP Not yet graded
CA licensed ingredient
Market presence34 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-006454
Fragaria Vesca Fruit US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Amino Acid [EPC]; Amino Acids [CS]; Bee Venoms [CS]
Market presence10 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-006455
Fragaria Vesca Whole US-DRUG Not yet graded
US: unapproved homeopathic
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-006456
Fragaria virginiana CA-NHP Not yet graded
CA licensed ingredient
Market presence53 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-006457
Fragaria x ananassa CA-NHP Not yet graded
CA licensed ingredient
Market presence162 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-006458
Fragaria x ananassa (Duchesne ex Weston) Duchesne ex Rozier EU-NOVEL Not yet graded
Not novel in food
Parts in scopeInfusion of the leaves and fruits; Leaves
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-006460
Fragaria x ananassa cv. Orleans CA-NHP Not yet graded
CA licensed ingredient
Market presence4 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-006459
Fragariae folium EU-HERB Not yet graded
Herbal monograph: F: Assessment finalised
also: Wild Strawberry Leaf; Fragaria vescaL.;Fragaria moschataWeston;Fragaria viridisWeston;Fragaria x ananassa (Weston) Duchesne ex Rozier
Class as recordedherbal: Urinary tract and genital disorders;Gastrointestinal disorde
Recorded fromEU-HERB — 1 of 7 registers
Etalyn identifierETA-C-006461
Fragrance 13576 US-DRUG Not yet graded
US: otc monograph final
Class as recordedAcidifying Activity [MoA]; Allergens [CS]; Ammonium Ion Binding Activity [MoA]; Anti-coagulant [EPC]
Market presence18 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-006462
Franciscea uniflora CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-006463
Francisella Tularensis US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAcetylcholine Release Inhibitor [EPC]; Acetylcholine Release Inhibitors [MoA]; Allergens [CS]; Blood Coagulation Factor [EPC]
Market presence5 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-006464
Frangula alnus CA-NHPEU-NOVEL Not yet graded
Not novel in supplementsCA licensed ingredient
also: Frangula dodonei Ard., Rhamnus frangula L.
Market presence113 Canadian licensed products
Parts in scopeBark; Herbal infusions of the bark
Recorded fromCA-NHP, EU-NOVEL — 2 of 7 registers
Etalyn identifierETA-C-006465
Frangula Alnus Bark US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAdrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]; Allergens [CS]; Ammonium Ion Binding Activity [MoA]
Market presence18 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-006466
Frangula californica CA-NHP Not yet graded
CA licensed ingredient
Market presence5 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-006467
Frangula Californica Bark US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Ascorbic Acid [CS]; Bee Venoms [CS]; Cell-mediated Immunity [PE]
Market presence4 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-006468
Frangula purshiana CA-NHP Not yet graded
CA licensed ingredient
Market presence363 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-006469
Frangula Purshiana Bark US-DRUG Not yet graded
US: drug for further processing
Class as recordedAdrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]; Allergens [CS]; Ammonium Ion Binding Activity [MoA]
Market presence30 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-006470
Frangulae cortex EU-HERB Not yet graded
Herbal monograph: F: Assessment finalised
also: Frangula bark; Rhamnus frangulaL.
Class as recordedherbal: Constipation
Recorded fromEU-HERB — 1 of 7 registers
Etalyn identifierETA-C-006471
Frankincense US-DRUG Not yet graded
US: otc monograph drug
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Food Additives [CS]
Market presence12 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-006472
Fraxini folium EU-HERB Not yet graded
Herbal monograph: F: Assessment finalised
also: Ash Leaf; Fraxinus excelsiorL.;Fraxinus angustifoliaVahl
Class as recordedherbal: Pain and inflammation;Urinary tract and genital disorders
Recorded fromEU-HERB — 1 of 7 registers
Etalyn identifierETA-C-006473
Fraxinus CA-NHP Not yet graded
CA licensed ingredient
Market presence4 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-006474
Fraxinus americana CA-NHP Not yet graded
CA licensed ingredient
Market presence25 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-006475
Fraxinus Americana Bark US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAcidifying Activity [MoA]; Adrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Adrenocorticotropic Hormone [CS]
Market presence25 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-006476
Fraxinus Americana Pollen US-DRUG Not yet graded
US: bla
Class as recordedAdrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Allergens [CS]; Blood Coagulation Factor [EPC]
Market presence84 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-006477
Fraxinus Americana Whole US-DRUG Not yet graded
US: unapproved homeopathic
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-006478
Fraxinus angustifolia CA-NHP Not yet graded
CA licensed ingredient
Market presence6 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-006479
Fraxinus chinensis CA-NHP Not yet graded
CA licensed ingredient
Market presence36 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-006480
Fraxinus chinensis subsp. rhynchophylla CA-NHP Not yet graded
CA licensed ingredient
Market presence11 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-006481
Fraxinus excelsior CA-NHP Not yet graded
CA licensed ingredient
Market presence32 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-006482
Fraxinus Excelsior Bark US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-006483
Fraxinus Excelsior Leaf US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Antimalarial [EPC]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]
Market presence3 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-006484
Fraxinus Excelsior Pollen US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAdrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]; Allergens [CS]; Cell-mediated Immunity [PE]
Market presence5 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-006485
Fraxinus Latifolia Pollen US-DRUG Not yet graded
US: bla
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]
Market presence4 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-006486
Fraxinus Latifolia Whole US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAdrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]; Allergens [CS]; Cell-mediated Immunity [PE]
Market presence6 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-006487
Fraxinus ornus CA-NHPEU-NOVEL Not yet graded
Not novel in foodCA licensed ingredient
also: Manna ash
Market presence7 Canadian licensed products
Parts in scopeResin of the bark of the tree
Recorded fromCA-NHP, EU-NOVEL — 2 of 7 registers
Etalyn identifierETA-C-006488
Fraxinus Pennsylvanica Pollen US-DRUG Not yet graded
US: bla
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Grain Proteins [EXT]
Market presence28 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-006489
Fraxinus stylosa CA-NHP Not yet graded
CA licensed ingredient
Market presence3 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-006490
Fraxinus szaboana CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-006491
Fraxinus Velutina Pollen US-DRUG Not yet graded
US: bla
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]
Market presence31 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-006492
Free Plant Stanols CA-NHP Not yet graded
CA licensed ingredient
Market presence45 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-006493
Free plant sterols CA-NHP Not yet graded
CA licensed ingredient
Market presence505 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-006494
Fremanezumab EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bla
Class as recordedN02CD03
Market presence3 US product listings · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-006495
Fremanezumab-Vfrm US-DRUG Not yet graded
Earliest US approval2018
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-006496
Friedlander Bacillus of Pneumonia CA-NHP Not yet graded
CA licensed ingredient
Market presence3 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-006497
Fritillaria CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-006498
Fritillaria cirrhosa CA-NHP Not yet graded
CA licensed ingredient
Market presence181 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-006499